PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
09-Feb-2023 Aura Biosciences to Participate in Upcoming Investor Conferences Businesswire
09-Feb-2023 Labcorp Unveils New Name for Future Independent Clinical Development Business - Fortrea Businesswire
09-Feb-2023 Aldeyra Therapeutics to Participate in Fireside Chat at the SVB Securities Global Biopharma Conference Businesswire
09-Feb-2023 Prokarium Announces $30 Million Financing to Deliver Lead Program into Clinic and Build Novel Therapeutic Platform Businesswire
09-Feb-2023 Global Genomic Cancer Panel and Profiling Markets Report 2023-2027 with Screening Potential Market Size, Customized Forecasting/Analysis, & Executive and Consultant Guides - ResearchAndMarkets.com Businesswire
09-Feb-2023 Molecular Diagnostics for Cancer Markets Report 2023: The Emergence of New Economies with Large Markets - ResearchAndMarkets.com Businesswire
09-Feb-2023 Takeda schließt Übernahme der TYK2-Programm-Tochter von Nimbus Therapeutics ab Businesswire
09-Feb-2023 Global KRAS Inhibitors Market Report to 2029: Featuring Ascentage Pharma, AstraZeneca, Boehringer Ingelheim and BridgeBio Pharma Among Others - ResearchAndMarkets.com Businesswire
09-Feb-2023 Insights on the Smart Packaging Global Market to 2027 - by Technology, End-user and Region - ResearchAndMarkets.com Businesswire
09-Feb-2023 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
09-Feb-2023 Celyad Oncology Announces the Publication of Data From Its Phase 1 THINK Study of CYAD-01 Businesswire
09-Feb-2023 SeqOne Genomics and the French Thrombotic MicroAngiopathies National Reference Center (CNR-MAT) Pioneer the Use of Oxford Nanopore Sequencing Technology to Improve Patient Outcomes in Kidney Disease While Reducing Turnaround Times Businesswire
09-Feb-2023 Takeda finaliza la adquisición de la filial del programa TYK2 de Nimbus Therapeutics Businesswire
09-Feb-2023 Takeda finalise l’acquisition de la filiale de Nimbus Therapeutics consacrée au programme TYK2 Businesswire
09-Feb-2023 Takeda Completes Acquisition of Nimbus Therapeutics’ TYK2 Program Subsidiary Businesswire
09-Feb-2023 Nimbus Therapeutics Announces Closing of Takeda’s Acquisition of TYK2 Subsidiary Businesswire
09-Feb-2023 Sweet Biopharma Day’s 3rd Edition | Québec, Canada Businesswire
09-Feb-2023 Toragen, Inc. Announces Appointment of Chief Scientific Officer Businesswire
09-Feb-2023 Atara Biotherapeutics Announces Fourth Quarter and Full Year 2022 Financial Results and Operational Progress Businesswire
09-Feb-2023 BELLUS Health to Present on the Patient Experience and the Burden of Refractory Chronic Cough at the American Academy of Allergy, Asthma & Immunology Annual Meeting Businesswire